Synchroline

Synchroline is an Italian dermocosmetic skincare brand based in Salò, on the shores of Lake Garda in the province of Brescia. It develops treatments for conditions such as acne, rosacea, hyperpigmentation and ageing, and is sold mainly through pharmacies and on recommendation from dermatologists. The brand is the dermocosmetics line of General Topics S.r.l., the company founded by the dermatologist Dr Gianfranco de Paoli Ambrosi that also owns it today [5]. The brand remains active, with a live e-commerce site, a current catalogue and distribution across several regions.

According to the company's own history, Synchroline was born in 1992 in Salò, emerging from the historic Dr. de Paoli pharmacy [3]. Its corporate parent gives the same year, noting that the underlying research began in 1987 and that the company was formally established in 1992 [5]. One reseller listing has stated a founding date of 1990 for General Topics; the brand and its parent both record 1992, and that year is used here [8].

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

Synchroline traces its roots to the Dr. de Paoli pharmacy in Salò, described by the company as a historic Italian shop recognised by the regional authorities of Lombardy. From that pharmacy came what the brand calls pioneering research into the biomechanical properties of skin and the mechanisms of wound healing [3]. That work produced the first product line, Terproline, aimed at mature skin and loss of firmness.

The founder, Dr Gianfranco de Paoli Ambrosi, established General Topics S.r.l. in 1992 as the parent company under which Synchroline would operate [5].

Synchroline is one of three business units of General Topics S.r.l., which is based at Via Enrico Fermi in Salò. The company describes Synchroline as its dermocosmetics range, alongside two sister units: Tebitech, focused on technology and biotechnology for dermatology and plastic surgery, and Fillast, a cosmetics line [6]. No acquisition history is recorded; the brand has remained under the same ownership since its founding.

The company states that its mission, sustained for more than 30 years, is to improve skin health through the research and development of dermocosmetic treatments that are effective, safe and well tolerated. It frames its work around the meeting of cosmetics and dermatology, and lists three core values: science, innovation and quality, with efficacy and safety tested under medical supervision.

Synchroline describes its guiding method as Technosophy, which it presents as an original approach fusing philosophy, applied technology and scientific innovation [4]. A related concept, which the company calls the Magic Triangle, links science, technology and usability — the last referring to ease and pleasantness of use. The brand positions itself as recommended by dermatologists worldwide and emphasises a "Made in Italy" identity.

The Synchroline catalogue is organised into targeted lines addressing specific skin concerns. Terproline, the founding range, is aimed at mature skin. Aknicare covers acne-prone skin; the brand markets its Aknicare Cream as a medical device for mild-to-moderate acne [10]. Other lines include Rosacure for rosacea and redness, Thiospot for hyperpigmentation, Synchrovit for wrinkles and ageing, and further ranges spanning atopic skin, sensitive skin, sun protection and body care.

The company states that its products are developed in Italian laboratories through years of research, clinical testing and collaboration with the medical world [3]. It describes a "Synchronized Effect" formulation principle, in which several functional ingredients are combined so that they act in synergy. On patents, the figures reported depend on scope: the Synchroline brand states it has filed more than 30 international patents [4], while its parent, General Topics, cites over 90 patents extended internationally across all of its business units [5].

Synchroline is an active brand. It maintains a live e-commerce site and a current product catalogue, and states distribution across North America, Europe, the Middle East, Africa and Asia, sold through pharmacies and authorised resellers.